
An announcement from PMGC Holdings ( ($ELAB) ) is now available. On November 5, 2026, PMGC announced completion of an eight-week preclinical study evaluating EL-32 alone and with semaglutide in
Compare up to 40 stocks
Compared Stocks: 1 / 40
| Ticker | Company Name | Price | Change | % Change | |
|---|---|---|---|---|---|
| ELAB | PMGC Holdings | 1.58 | -1,270.42 | -99.88% |
| Name | Price | % Change | |
|---|---|---|---|
| $1.58 | -99.88% |

An announcement from PMGC Holdings ( ($ELAB) ) is now available. On November 5, 2026, PMGC announced completion of an eight-week preclinical study evaluating EL-32 alone and with semaglutide in

The latest update is out from PMGC Holdings ( ($ELAB) ). On October 30, 2026, PMGC Holdings Inc. agreed to subscribe for US$1.845 million of secured, non-interest-bearing debentures issued by

An announcement from PMGC Holdings ( ($ELAB) ) is now available. On October 28, 2026, PMGC Holdings prepared an updated corporate slide deck and a separate maritime defense technology deck

PMGC (ELAB) Holdings announces that it has registered a doing-business-as name as NorthStrive Holdings, Inc. and entered into a Trademark License Agreement with NorthStrive Companies Inc., authorizing the company’s use

PMGC (ELAB) Holdings announced that it is the sponsor of NorthStrive Acquisition Corp I., marking the launch of PMGC’s special purpose acquisition company, SPAC, sponsorship platform. Published first on TheFly

PMGC (ELAB) Holdings (PMGC) announced that its subsidiary, NorthStrive Biosciences has executed a Statement of Work with Charles River Laboratories (CRL) to conduct analytical characterization supporting the development of NorthStrive

The latest update is out from PMGC Holdings ( ($ELAB) ). On September 18, 2026, PMGC Holdings Inc. and its wholly owned subsidiary NorthStrive Biosciences Inc. entered into an interest-bearing

PMGC (ELAB) announced that the Company and its wholly owned subsidiary, NorthStrive Biosciences, have entered into a fully executed, interest-bearing payment agreement with Longevity Health Holdings, formerly known as Carmell,

PMGC Holdings ( ($ELAB) ) just unveiled an announcement. On August 27, 2026, NorthStrive Biosciences, a wholly owned subsidiary of PMGC Holdings, executed a First Amendment to its Development and

PMGC Holdings ( ($ELAB) ) has provided an announcement. On August 27, 2026, PMGC Holdings entered a five-year trademark license agreement with NorthStrive Companies Inc., gaining limited, royalty-free rights to
Compare Stocks Side-by-Side
Our stock comparison tool allows investors to compare multiple stocks simultaneously, providing comprehensive insights into key metrics, financial data, and analyst ratings. Make informed investment decisions by analyzing stocks side by side.
Key Features of Our Stock Comparison
How to Use the Stock Comparison Tool
Simply enter the ticker symbols of the stocks you want to compare in the search box above. You can add up to 40 stocks at once. The tool will automatically populate comparison tables with the latest data, allowing you to analyze and contrast different investment opportunities across various sectors and industries.
Popular Stock Comparisons
Investors frequently compare stocks within the same sector to identify the best investment opportunities. Popular comparisons include tech giants like Apple (AAPL) vs. Microsoft (MSFT), semiconductor leaders Nvidia (NVDA) vs. AMD, beverage companies Coca-Cola (KO) vs. Pepsi (PEP), and electric vehicle makers Tesla (TSLA) vs. Rivian (RIVN).
Why Compare Stocks?
Comparing stocks helps investors identify which companies offer the best value, growth potential, and risk-adjusted returns. By analyzing multiple stocks side by side, you can better understand relative valuations, competitive advantages, and market positioning before making investment decisions.